Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting this week at the 43^rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA (U.S.A.). 

The presentation will take place this Wednesday, 15 January at 2:15 pm PST (5:15 pm EST / 9:15 am AEDT, 16 January). 

Participants can register for the webcast at the following link and the webcast presentation can be downloaded here.

The webcast will be accessible on demand on the Telix website following the event.